Nesprin-1 mutations in human and murine cardiomyopathy
- 30 April 2010
- journal article
- Published by Elsevier BV in Journal of Molecular and Cellular Cardiology
- Vol. 48 (4), 600-608
- https://doi.org/10.1016/j.yjmcc.2009.11.006
Abstract
No abstract availableFunding Information
- NIH (HL092443)
This publication has 51 references indexed in Scilit:
- Telavancin Pharmacokinetics and Pharmacodynamics in Patients with Complicated Skin and Skin Structure Infections and Various Degrees of Renal FunctionAntimicrobial Agents and Chemotherapy, 2012
- Telavancin versus Vancomycin for HospitalAcquired Pneumonia due to Gram-positive PathogensClinical Infectious Diseases, 2010
- Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid IIAntimicrobial Agents and Chemotherapy, 2009
- Disruption of nesprin-1 produces an Emery Dreifuss muscular dystrophy-like phenotype in miceHuman Molecular Genetics, 2008
- Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type laminsHuman Molecular Genetics, 2008
- Structural requirements for the assembly of LINC complexes and their function in cellular mechanical stiffnessExperimental Cell Research, 2008
- Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system diseaseJournal of Molecular and Cellular Cardiology, 2008
- Intrapulmonary Distribution of Intravenous Telavancin in Healthy Subjects and Effect of Pulmonary Surfactant on In Vitro Activities of Telavancin and Other AntibioticsAntimicrobial Agents and Chemotherapy, 2008
- SUN1 Interacts with Nuclear Lamin A and Cytoplasmic Nesprins To Provide a Physical Connection between the Nuclear Lamina and the CytoskeletonMolecular and Cellular Biology, 2006
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976